Introduction
Mixed inflammation characteristics on lower and upper airways mucosa among certain patients conditions inflammatory process specifics and BA flow, mixed with various allergic rhinitis types. Control effectiveness depends on timely inflammatory process activity evaluation. Local cytokine profile parameters research allows not only control inflammation and assess therapy effectiveness among such patients, but also timely prevent pathology severeness increase and complications formation.
Materials and Methods
Research method was as follows: key cytokines local fracture assessment using immunoenzymatic approach – IL-2, IL-4, IL-8, IL-10, γ – INF, α-TNF in nasal lavage among 57 patients in non-exacerbation period, suffering from BA and various perennial allergic rhinitis phenotypes. Research also included 21 patient, suffering from comorbid vascular dystonia, 25 patients, suffering from comorbid herpetic viral infection. Control group consisted of 11 patients without any comorbid pathology.
Results
Control group patients show reliable IL-10 and γ – INF content change in nasal secret. Patients, suffering from comorbid herpetic viral infection showed rapid γ – INF content decrease, IL-8 production increase and α-TNF content changes in herpetic viral infection exacerbation period. Patients, associated to vascular dystonia, showed IL-2 and IL-8 level change.
Conclusions
Local nasal mucosa inflammatory process pathogenesis is an effective inflammation control biomarker not only for various allergic rhinitis phenotypes, but also for patients, suffering from BA and various allergic rhinitis phenotypes. Alongside with effectiveness, simplicity and non-invasive character this method is economically attractive, which is the sufficient reason to include it in recommendations on treatment of patients, suffering from BA, mixed with various allergic rhinitis phenotypes.
Article info
Publication history
P005
Identification
Copyright
© 2020 Published by Elsevier Inc.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
